(Reuters) – UCB SA said on Monday the U.S. Food and Drug Administration (FDA) approved its drug to treat seizures associated with Lennox-Gastaut Syndrome (LGS), a rare form of childhood epilepsy.
(Reporting by Bhanvi Satija, Manojna Maddipatla and Ann Maria Shibu in Bengaluru; Editing by Devika Syamnath and Sherry Jacob-Phillips)
